Branch programme/details

The study program Personalized Diagnostics and Therapy in Oncology aims to provide and enhance its students' knowledge regarding the causes, prevention, diagnosis, and treatment of oncological diseases and their related risk factors and comorbidities, with a focus on customizing and individualizing the diagnostic and treatment processes.

Study program without specialization.

The entrance examination takes the form of an interview in which professional and language skills are examined primarily as well as the readiness of applicant for independent scientific work in the chosen field. Interviews comprise of:

1. English language (0-20 points) - the applicant's ability to describe the proposed project in English and then discuss it.

2. Specialized topic (0-40 points) - the quality of the dissertation project and the level of preparation of its annotation, the relation of the submitted project to the focus of the intended supervisor and the financial aspect of the project.  

3. Examination from the field (0-30 points) - the applicant's basic theoretical knowledge in relation to the dissertation topic and general overview.

4. Publications and lecturing activities (0-10 points).

At least 70 points are required for successful passing of the entrance interview.

In order to be admitted to the full-time study, an applicant must obtain the minimum number of points for successful completion of the entrance examination and at the same time obtain the minimum number of points required for admission. The minimum number of points for admission is determined by the Dean on the basis of the results of the entrance examinations, taking into account the expected number of admitted applicants and the economic and capacity possibilities of the faculty. To be admitted to the combined study, an applicant must obtain a minimum number of points for successful completion of the entrance examination which equals to the minimum number of points required for admission.

Admission to Doctoral studies is conditioned by successful completion of a Master's study programme.

Literature: S. Offermanns, W. Rosenthal: Encyclopedic reference of molecular pharmacology 2004 – Springer H.G. Vogel, W.H. Fogel: Drug discovery and evalvation (Pharmacological essay) 1997 – Springer L.L. Brunton, J.S. Lazo, K.L. Parker: Goodman and Gilman´s The pharmacological basis of therapeutics. Mc Graw-Hill 2006

Graduates will work as clinical specialists, academic and scientific staff at universities and research institutions, and as researchers in the biotechnology and biomedical sectors. Typical employers will be universities, research institutions, healthcare facilities including teaching hospitals.